Burmester, G. R., Rubbert-Roth, A., Cantagrel, A., Hall, S., Leszczynski, P., Pollak, D. F. [., . . . Mysler, E. F. (2014). A randomised, double-blind, parallel-group study of the safety and efficacy of subcutaneous tocilizumab versus intravenous tocilizumab in combination with traditional disease-modifying antirheumatic drugs in patients with moderate to severe rheumatoid arthritis (SUMMACTA study).
Citación estilo ChicagoBurmester, Gerd R., et al. A Randomised, Double-blind, Parallel-group Study of the Safety and Efficacy of Subcutaneous Tocilizumab Versus Intravenous Tocilizumab in Combination With Traditional Disease-modifying Antirheumatic Drugs in Patients With Moderate to Severe Rheumatoid Arthritis (SUMMACTA Study). 2014.
Cita MLABurmester, Gerd R., et al. A Randomised, Double-blind, Parallel-group Study of the Safety and Efficacy of Subcutaneous Tocilizumab Versus Intravenous Tocilizumab in Combination With Traditional Disease-modifying Antirheumatic Drugs in Patients With Moderate to Severe Rheumatoid Arthritis (SUMMACTA Study). 2014.